Evaxion A (EVAX) Exchange Rate Effect (2020 - 2022)
Evaxion A posted quarterly Exchange Rate Effect of -$590000.0 for Q2 2022, down 734.41% year-on-year from $93000.0 in Q2 2021, and down 293.33% on a QoQ basis from -$150000.0 in Q1 2022.
Evaxion A (EVAX) has 3 years of Exchange Rate Effect data on file, last reported at -$590000.0 in Q2 2022.
- For the quarter ending Q2 2022, Exchange Rate Effect fell 734.41% year-over-year to -$590000.0; the trailing twelve-month figure through Jun 2022 stood at -$718000.0 (down 350.17% YoY), and the FY2025 full-year result was $1.5 million, up 725.68% from the prior year.
- Exchange Rate Effect for Q2 2022 stood at -$590000.0, down from -$150000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $231000.0 in Q1 2021 and bottomed at -$590000.0 in Q2 2022.
- The 3-year median for Exchange Rate Effect is -$65000.0 (2020), against an average of -$86125.0.
- The widest annual swing landed in 2021, when Exchange Rate Effect soared 257.63%; it then tumbled 734.41% in 2022.
- A 3-year view of Exchange Rate Effect shows it stood at $22000.0 in 2020, then plunged by 422.73% to -$71000.0 in 2021, then plunged by 730.99% to -$590000.0 in 2022.
- The last three Exchange Rate Effect figures came in at -$590000.0 (Q2 2022), -$150000.0 (Q1 2022), and -$71000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -590,000.00 |
| Jun 30, 2022 | -590,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Mar 31, 2020 | -165,000.00 |
| Mar 31, 2020 | -165,000.00 |